TCG Crossover Management, LLC Diversified Active

CIK: 0001839948 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $901,702 (100.0% shares, 0.0% debt)

Holdings (29)

GPCR STRUCTURE THERAPEUTICS INC 9.5%

Value ($000) $85,987 Shares 2,109,584 Est. Cost $43.22 Unrealized —

— INHIBRX,INC 7.4%

Value ($000) $66,515 Shares 1,750,387 Est. Cost $18.35 Unrealized —

— ICOSAVAX INC 6.5%

Value ($000) $58,370 Shares 3,703,704 Est. Cost $9.93 Unrealized —

ANTX AN2 Therapeutics, Inc. 6.1%

Value ($000) $54,877 Shares 2,678,209 Est. Cost $9.33 Unrealized +79.2%

— RAYZEBIO, INC. 6.0%

Value ($000) $54,082 Shares 869,908 Est. Cost $22.20 Unrealized —

— AEROVATE THERAPEUTICS INC 5.5%

Value ($000) $49,815 Shares 2,201,274 Est. Cost $15.75 Unrealized —

GERN GERON CORP 5.5%

Value ($000) $49,323 Shares 23,375,839 Est. Cost $1.89 Unrealized +3.1%

SVRA SAVARA INC. 5.2%

Value ($000) $47,000 Shares 10,000,000 Est. Cost $3.56 Unrealized +7.5%

— GRACELL BIOTECHNOLOGIES INC. 5.0%

Value ($000) $45,328 Shares 4,514,786 Est. Cost $5.22 Unrealized —

MDGL MADRIGAL PHARMACEUTICALS INC 4.6%

Value ($000) $41,629 Shares 179,917 Est. Cost $110.42 Unrealized +58.5%

KALV KALVISTA PHARMACEUTICALS, INC 4.6%

Value ($000) $41,595 Shares 3,395,495 Est. Cost $5.36 Unrealized +69.8%

SLN SILENCE THERAPEUTICS PLC 4.1%

Value ($000) $36,562 Shares 2,104,875 Est. Cost $10.03 Unrealized —

CMPS COMPASS PATHWAYS PLC 3.7%

Value ($000) $33,758 Shares 3,858,000 Est. Cost $7.40 Unrealized —

COGT COGENT BIOSCIENCES INC 3.7%

Value ($000) $33,111 Shares 5,631,042 Est. Cost $9.54 Unrealized -19.7%

TYRA TYRA BIOSCIENCES INC 3.1%

Value ($000) $27,549 Shares 1,989,103 Est. Cost $12.71 Unrealized +1.9%

— TOURMALINE BIO INC 2.9%

Value ($000) $26,387 Shares 1,007,902 Est. Cost $26.18 Unrealized —

TARS TARSUS PHARMACEUTICALS, INC. 2.6%

Value ($000) $23,143 Shares 1,142,857 Est. Cost $17.70 Unrealized -5.6%

DYN DYNE THERAPEUTICS, INC 2.4%

Value ($000) $21,947 Shares 1,650,150 Est. Cost $12.99 Unrealized -24.8%

KURA KURA ONCOLOGY INC 2.3%

Value ($000) $20,472 Shares 1,423,642 Est. Cost $14.54 Unrealized -32.4%

CNTA CENTESSA PHARMACEUTICALS PLC 1.8%

Value ($000) $16,245 Shares 2,040,816 Est. Cost $6.47 Unrealized —

— VISTAGEN THERAPEUTICS INC 1.5%

Value ($000) $13,758 Shares 2,676,580 Est. Cost $5.14 Unrealized —

ABVX Abivax SA 1.3%

Value ($000) $11,770 Shares 1,100,000 Est. Cost $10.70 Unrealized —

CABA CABALETTA BIO, INC 1.2%

Value ($000) $11,050 Shares 486,795 Est. Cost $3.64 Unrealized +361.8%

TRDA ENTRADA THERAPEUTICS INC 1.0%

Value ($000) $8,827 Shares 584,955 Est. Cost $17.12 Unrealized —

NRIX NURIX THERAPEUTICS INC 0.8%

Value ($000) $7,406 Shares 717,654 Est. Cost $6.85 Unrealized 0.0%

CCCC C4 THERAPEUTICS, INC. 0.8%

Value ($000) $7,213 Shares 1,276,574 Est. Cost $5.83 Unrealized -60.9%

TSHA TAYSHA GENE THERAPIES, INC. 0.6%

Value ($000) $5,156 Shares 2,912,861 Est. Cost $1.87 Unrealized +6.7%

VTYX VENTYX BIOSCIENCES, INC 0.2%

Value ($000) $2,015 Shares 815,724 Est. Cost $29.94 Unrealized -68.3%

KOD KODIAK SCIENCES INC 0.1%

Value ($000) $815 Shares 267,941 Est. Cost $2.22 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GPCR	STRUCTURE THERAPEUTICS INC	2,109,584	$85,987	9.5%	$43.22	—	ADRS	86366E106
—	INHIBRX,INC	1,750,387	$66,515	7.4%	$18.35	—	COMM	45720L107
—	ICOSAVAX INC	3,703,704	$58,370	6.5%	$9.93	—	COMM	45114M109
ANTX	AN2 Therapeutics, Inc.	2,678,209	$54,877	6.1%	$9.33	+79.2%	COMM	037326105
—	RAYZEBIO, INC.	869,908	$54,082	6.0%	$22.20	—	COMM	75525N107
—	AEROVATE THERAPEUTICS INC	2,201,274	$49,815	5.5%	$15.75	—	COMM	008064107
GERN	GERON CORP	23,375,839	$49,323	5.5%	$1.89	+3.1%	COMM	374163103
SVRA	SAVARA INC.	10,000,000	$47,000	5.2%	$3.56	+7.5%	COMM	805111101
—	GRACELL BIOTECHNOLOGIES INC.	4,514,786	$45,328	5.0%	$5.22	—	ADRS	38406L103
MDGL	MADRIGAL PHARMACEUTICALS INC	179,917	$41,629	4.6%	$110.42	+58.5%	COMM	558868105
KALV	KALVISTA PHARMACEUTICALS, INC	3,395,495	$41,595	4.6%	$5.36	+69.8%	COMM	483497103
SLN	SILENCE THERAPEUTICS PLC	2,104,875	$36,562	4.1%	$10.03	—	ADRS	82686Q101
CMPS	COMPASS PATHWAYS PLC	3,858,000	$33,758	3.7%	$7.40	—	ADRS	20451W101
COGT	COGENT BIOSCIENCES INC	5,631,042	$33,111	3.7%	$9.54	-19.7%	COMM	19240Q201
TYRA	TYRA BIOSCIENCES INC	1,989,103	$27,549	3.1%	$12.71	+1.9%	COMM	90240B106
—	TOURMALINE BIO INC	1,007,902	$26,387	2.9%	$26.18	—	COMM	89157D105
TARS	TARSUS PHARMACEUTICALS, INC.	1,142,857	$23,143	2.6%	$17.70	-5.6%	COMM	87650L103
DYN	DYNE THERAPEUTICS, INC	1,650,150	$21,947	2.4%	$12.99	-24.8%	COMM	26818M108
KURA	KURA ONCOLOGY INC	1,423,642	$20,472	2.3%	$14.54	-32.4%	COMM	50127T109
CNTA	CENTESSA PHARMACEUTICALS PLC	2,040,816	$16,245	1.8%	$6.47	—	COMM	152309100
—	VISTAGEN THERAPEUTICS INC	2,676,580	$13,758	1.5%	$5.14	—	COMM	92840H202
ABVX	Abivax SA	1,100,000	$11,770	1.3%	$10.70	—	COMM	00370M103
CABA	CABALETTA BIO, INC	486,795	$11,050	1.2%	$3.64	+361.8%	COMM	12674W109
TRDA	ENTRADA THERAPEUTICS INC	584,955	$8,827	1.0%	$17.12	—	COMM	29384C108
NRIX	NURIX THERAPEUTICS INC	717,654	$7,406	0.8%	$6.85	0.0%	COMM	67080M103
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$7,213	0.8%	$5.83	-60.9%	COMM	12529R107
TSHA	TAYSHA GENE THERAPIES, INC.	2,912,861	$5,156	0.6%	$1.87	+6.7%	COMM	877619106
VTYX	VENTYX BIOSCIENCES, INC	815,724	$2,015	0.2%	$29.94	-68.3%	COMM	92332V107
KOD	KODIAK SCIENCES INC	267,941	$815	0.1%	$2.22	0.0%	COMM	50015M109